A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)

Clinical trial NCT02056808 · COMPLETED

Trial details

NCT number: NCT02056808
Sponsor: Summit Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2013-11-01
Primary completion: 2014-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.